Latest & greatest articles for triamcinolone

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on triamcinolone or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on triamcinolone and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for triamcinolone

1. Randomized double-blinded clinical trial of 5% dextrose versus triamcinolone injection for carpal tunnel syndrome patients

Randomized double-blinded clinical trial of 5% dextrose versus triamcinolone injection for carpal tunnel syndrome patients 30187524 2018 10 16 1531-8249 84 4 2018 Oct Annals of neurology Ann. Neurol. Randomized double-blinded clinical trial of 5% dextrose versus triamcinolone injection for carpal tunnel syndrome patients. 601-610 10.1002/ana.25332 Perineural injection with 5% dextrose (D5W) is a novel strategy in the treatment of carpal tunnel syndrome (CTS). In contrast, perineural injection (...) of perineural injection with 5ml D5W (dextrose group) or 3ml triamcinolone acetonide mixed with 2ml normal saline (steroid group), under ultrasound guidance. A visual analog scale was assigned to assess the primary outcome. The secondary outcomes were assessed using the Boston Carpal Tunnel Syndrome Questionnaire, cross-sectional area of the median nerve, and electrophysiological studies. The assessment was performed prior to injection and 1, 3, 4, and 6 months postinjection. All patients (27 wrists per

EvidenceUpdates2018

2. Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study

Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study 30203101 2018 09 11 1462-0332 2018 Sep 06 Rheumatology (Oxford, England) Rheumatology (Oxford) Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study. 10.1093/rheumatology/key265 Approximately 30% of patients with type 2 diabetes mellitus have knee osteoarthritis. IA corticosteroids used to manage (...) osteoarthritis pain can elevate blood glucose in these patients. We compared blood glucose levels following intra-articular injection of triamcinolone acetonide extended-release (TA-ER), an extended-release, microsphere-based triamcinolone acetonide formulation, vs standard triamcinolone acetonide crystalline suspension (TAcs) in patients with knee osteoarthritis and comorbid type 2 diabetes. In this double-blind, randomized, parallel-group, phase 2 study (NCT02762370), 33 patients with knee osteoarthritis

EvidenceUpdates2018

3. Triamcinolone

Triamcinolone Top results for triamcinolone - Trip Database or use your Google+ account Liberating the literature My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing (...) the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for triamcinolone The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines

Trip Latest and Greatest2018

4. Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study

Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study 29664853 2018 06 15 1535-1386 100 8 2018 Apr 18 The Journal of bone and joint surgery. American volume J Bone Joint Surg Am Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo (...) -Controlled, Multinational Study. 666-677 10.2106/JBJS.17.00154 Intra-articular corticosteroids relieve osteoarthritis pain, but rapid systemic absorption limits efficacy. FX006, a novel, microsphere-based, extended-release triamcinolone acetonide (TA) formulation, prolongs TA joint residence and reduces systemic exposure compared with standard TA crystalline suspension (TAcs). We assessed symptomatic benefits and safety of FX006 compared with saline-solution placebo and TAcs. In this Phase-3, multicenter

EvidenceUpdates2018 Full Text: Link to full Text with Trip Pro

5. Gamechanger? The Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients with Knee Osteoarthritis ? A Randomized Clinical Trial

Gamechanger? The Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients with Knee Osteoarthritis ? A Randomized Clinical Trial Gamechanger? The Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients with Knee Osteoarthritis – A Randomized Clinical Trial | Clinical Correlations Gamechanger? The Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients with Knee Osteoarthritis (...) months. An article published in Journal of the American Medical Association in 2017, “The Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients with Knee Osteoarthritis: A Randomized Clinical Trial,” explored this topic. How was the study designed? McAlindon et al performed a double-blinded, randomized, placebo-controlled trial of intra-articular administration of triamcinolone vs saline every 3 months over a 2-year period. Study participants were age 45

Clinical Correlations2018

6. Subcutaneous Injection of Triamcinolone and Lidocaine to Prevent Postherpetic Neuralgia

Subcutaneous Injection of Triamcinolone and Lidocaine to Prevent Postherpetic Neuralgia 28727702 2017 07 20 2017 07 20 2150-1149 20 5 2017 Jul Pain physician Pain Physician Subcutaneous Injection of Triamcinolone and Lidocaine to Prevent Postherpetic Neuralgia. 397-403 Herpes zoster (HZ) is associated with inflammation of the peripheral nerves, which is considered to be an important cause of postherpetic neuralgia (PHN). Interventions aimed at reducing this inflammation could prevent PHN. One (...) option is the epidural administration of corticosteroid and local anesthetic. However, several authors have reported a risk of arachnoiditis with epidural corticosteroids. Subcutaneous injection in an outpatient setting is a safer option. However, there is limited evidence of the effectiveness of this alternative for preventing PHN. The aim of this study was to assess the effectiveness of subcutaneous injection of triamcinolone and lidocaine for the prevention of PHN in elderly HZ patients

EvidenceUpdates2017

7. Triamcinolone hexacetonide - juvenile idiopathic arthritis

Triamcinolone hexacetonide - juvenile idiopathic arthritis %PDF-1.5 %���� 56 0 obj > endobj 74 0 obj >/Filter/FlateDecode/ID[ ]/Index[56 32]/Info 55 0 R/Length 89/Prev 277355/Root 57 0 R/Size 88/Type/XRef/W[1 2 1]>>stream h�bbd``b`� $��� � $�O��T�l?�5 �j��A�� V��iS !@��=HVH�b`bd8�``$��ϸ�+@�R / endstream endobj startxref 0 %%EOF 87 0 obj >stream h�b`````j````Q�̀ A� �bP��� ���� �y�I����� �(.�a8T�rs��8�I,jg &2?�����b�eT0�4. endstream endobj 57 0 obj >/Metadata 2 0 R/PageLayout/OneColumn/Pages 54

All Wales Medicines Strategy Group2017

8. Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial.

Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial. Importance: Synovitis is common and is associated with progression of structural characteristics of knee osteoarthritis. Intra-articular corticosteroids could reduce cartilage damage associated with synovitis but might have adverse effects on cartilage and periarticular bone. Objective: To determine the effects of intra-articular injection of 40 (...) mg of triamcinolone acetonide every 3 months on progression of cartilage loss and knee pain. Design, Setting, and Participants: Two-year, randomized, placebo-controlled, double-blind trial of intra-articular triamcinolone vs saline for symptomatic knee osteoarthritis with ultrasonic features of synovitis in 140 patients. Mixed-effects regression models with a random intercept were used to analyze the longitudinal repeated outcome measures. Patients fulfilling the American College of Rheumatology

JAMA2017

9. Triamcinolone hexacetonide - juvenile idiopathic arthritis (JIA).

Triamcinolone hexacetonide - juvenile idiopathic arthritis (JIA). Published 09 November 2015 Product Update: triamcinolone hexacetonide 20mg/mL suspension for injection SMC No. (1103/15) Intrapharm Laboratories Limited 9 October 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) on its use in Scotland. The advice is summarised as follows: ADVICE: following an abbreviated (...) submission triamcinolone hexacetonide is accepted for use within NHS Scotland. Indication under review: juvenile idiopathic arthritis (JIA). This submission relates to a new licence extension for JIA where previously an unlicensed preparation has been used. This is the first intra-articular corticosteroid licensed for JIA. Advice context: No part of this advice may be used without the whole of the advice being quoted in full. This advice represents the view of the Scottish Medicines Consortium

Scottish Medicines Consortium2015

10. Comparison of 2 Dosages of Intraarticular Triamcinolone for the Treatment of Knee Arthritis: Results of a 12-week Randomized Controlled Clinical Trial

Comparison of 2 Dosages of Intraarticular Triamcinolone for the Treatment of Knee Arthritis: Results of a 12-week Randomized Controlled Clinical Trial 26233499 2015 10 02 2016 07 14 2015 10 02 0315-162X 42 10 2015 Oct The Journal of rheumatology J. Rheumatol. Comparison of 2 Dosages of Intraarticular Triamcinolone for the Treatment of Knee Arthritis: Results of a 12-week Randomized Controlled Clinical Trial. 1865-8 10.3899/jrheum.141630 To determine whether a double dose of intraarticular (...) triamcinolone acetonide is more effective for knee arthritis than a 40-mg dose. In this 12-week randomized controlled clinical trial, 40 mg and 80 mg of intraarticular triamcinolone acetonide were compared in patients with knee arthritis. Evaluated variables included a Likert burden scale, visual analog scale pain scale, degree of arthritis activity, presence of swelling, and presence of functional limitation. Ninety-seven patients were randomized. No significant differences were observed between the groups

EvidenceUpdates2015

11. Effectiveness of Triamcinolone Hexacetonide Intraarticular Injection in Interphalangeal Joints: A 12-week Randomized Controlled Trial in Patients with Hand Osteoarthritis

Effectiveness of Triamcinolone Hexacetonide Intraarticular Injection in Interphalangeal Joints: A 12-week Randomized Controlled Trial in Patients with Hand Osteoarthritis 26233501 2015 10 02 2016 07 14 2017 02 03 0315-162X 42 10 2015 Oct The Journal of rheumatology J. Rheumatol. Effectiveness of Triamcinolone Hexacetonide Intraarticular Injection in Interphalangeal Joints: A 12-week Randomized Controlled Trial in Patients with Hand Osteoarthritis. 1869-77 10.3899/jrheum.140736 To evaluate (...) the effectiveness and tolerance of intraarticular injection (IAI) of triamcinolone hexacetonide (TH) for the treatment of osteoarthritis (OA) of hand interphalangeal (IP) joints. Sixty patients who underwent IAI at the most symptomatic IP joint were randomly assigned to receive TH/lidocaine (LD; n = 30) with TH 20 mg/ml and LD 2%, or just LD (n = 30). The injected joint was immobilized with a splint for 48 h in both groups. Patients were assessed at baseline and at 1, 4, 8, and 12 weeks by a blinded observer

EvidenceUpdates2015

12. Efficacy of Triamcinolone Hexacetonide versus Methylprednisolone Acetate Intraarticular Injections in Knee Osteoarthritis: A Randomized, Double-blinded, 24-week Study

Efficacy of Triamcinolone Hexacetonide versus Methylprednisolone Acetate Intraarticular Injections in Knee Osteoarthritis: A Randomized, Double-blinded, 24-week Study 26136485 2015 09 02 2016 06 06 2015 09 02 0315-162X 42 9 2015 Sep The Journal of rheumatology J. Rheumatol. Efficacy of Triamcinolone Hexacetonide versus Methylprednisolone Acetate Intraarticular Injections in Knee Osteoarthritis: A Randomized, Double-blinded, 24-week Study. 1677-84 10.3899/jrheum.150297 Intraarticular (IA (...) ) corticosteroid injections are broadly used in knee osteoarthritis (OA); however, the best corticosteroid agent is not well defined. The aim of the present study was to compare the efficacy of triamcinolone hexacetonide (TH) and methylprednisolone acetate (MA) injections in knee OA. Patients with symptomatic knee OA and Kellgren-Lawrence grade II or III were randomized to receive 40 mg of IA TH or MA. Evaluations were performed at 4, 12, and 24 weeks. The primary outcome was a change in the patient's

EvidenceUpdates2015

13. Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety

Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety CADTH Record Status (...) This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary with Critical Appraisal. 2013 Authors' conclusions Findings from

Health Technology Assessment (HTA) Database.2014

14. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind,

Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, 23434570 2014 02 28 2014 04 29 2015 11 19 1468-2060 73 4 2014 Apr Annals of the rheumatic diseases Ann. Rheum. Dis. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid (...) arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial. 654-61 10.1136/annrheumdis-2012-202735 An investigator-initiated, double-blinded, placebo-controlled, treat-to-target protocol (Clinical Trials:NCT00660647) studied whether adalimumab added to methotrexate and intra-articular triamcinolone as first-line treatment in early rheumatoid arthritis (ERA) increased the frequency

EvidenceUpdates2013

15. The place of triamcinolone in the treatment of asthma.

The place of triamcinolone in the treatment of asthma. The place of triamcinolone in the... preview & related info | Mendeley E-mail address Password ( ) Remember me …or sign in with Search Main Navigation › Short URL Annals of Internal Medicine ( 1961 ) Volume: 127 , Issue: 6 , Pages: 581-582 PubMed: Available from or Find this paper at: Abstract PURPOSE: To review the activity in clinical models, the efficacy, and the safety of antileukotrienes as a new class of antiasthma treatment. DATA

Annals of Internal Medicine2013

17. Adding Triamcinolone Improves Viscosupplementation: A Randomized Clinical Trial

Adding Triamcinolone Improves Viscosupplementation: A Randomized Clinical Trial 23100188 2013 01 21 2013 05 28 2017 02 20 1528-1132 471 2 2013 Feb Clinical orthopaedics and related research Clin. Orthop. Relat. Res. Adding triamcinolone improves viscosupplementation: a randomized clinical trial. 613-20 10.1007/s11999-012-2659-y Intraarticular injections, mainly using long-lasting corticosteroid suspensions, have long been used to treat knee osteoarthritis. Viscosupplementation is a relatively (...) three questions: Does the addition of triamcinolone to viscosupplementation (1) improve first-week pain and function compared with viscosupplementation alone, (2) diminish adverse effects of viscosupplementation alone, and (3) alter 6-month pain and function of viscosupplementation alone? We prospectively enrolled 104 patients with knee osteoarthritis and randomized them to receive either a single intraarticular injection (6 mL) of hylan GF-20 (Group viscosupplementation [Group VS]), or a single

EvidenceUpdates2013 Full Text: Link to full Text with Trip Pro

18. Meta-analysis of the effect of intravitreal bevacizumab versus intravitreal triamcinolone acetonide in central retinal vein occlusion

Meta-analysis of the effect of intravitreal bevacizumab versus intravitreal triamcinolone acetonide in central retinal vein occlusion Meta-analysis of the effect of intravitreal bevacizumab versus intravitreal triamcinolone acetonide in central retinal vein occlusion Meta-analysis of the effect of intravitreal bevacizumab versus intravitreal triamcinolone acetonide in central retinal vein occlusion Jin ZY, Zhu D, Tao Y, Wong IY, Jonas JB CRD summary This review found a similar improvement (...) in best-corrected visual acuity and central macular thickness among patients with central retinal vein occlusion (eye blood vessel blockage) after intravitreal injections with bevacizumab or triamcinolone acetonide. The reliability of the authors' conclusions is limited by the lack of reporting of included study quality, small sample sizes, and inclusion of mainly non-randomised studies. Authors' objectives To evaluate the effect of intravitreal bevacizumab for the treatment of central retinal vein

DARE.2013

19. Application of triamcinolone acetonide paste to the endotracheal tube reduces postoperative sore throat: a randomized controlled trial

Application of triamcinolone acetonide paste to the endotracheal tube reduces postoperative sore throat: a randomized controlled trial 21359615 2011 04 19 2011 08 04 2013 11 21 1496-8975 58 5 2011 May Canadian journal of anaesthesia = Journal canadien d'anesthesie Can J Anaesth Application of triamcinolone acetonide paste to the endotracheal tube reduces postoperative sore throat: a randomized controlled trial. 436-42 10.1007/s12630-011-9478-6 This study was performed to examine whether (...) applying triamcinolone acetonide paste as a lubricant to endotracheal tubes (ETTs) reduces the incidence and severity of postoperative sore throat (POST) more effectively than applying chlorhexidine gluconate jelly. This was a randomized controlled clinical trial. Patients enrolled in the study were ages 20 to 70 yr, American Society of Anesthesiologists' physical status I and II, and scheduled for elective laparoscopic cholecystectomy. The patients were divided randomly into two groups

EvidenceUpdates2011

20. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review

Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, Cervantes-Castaneda RA, Klisovic D, Lavaque AJ, Larson RJ CRD summary This review concluded (...) that intravitreal triamcinolone acetonide injection was effective in improving visual acuity patients with refractory diabetic macular oedema in the short-term. This was generally a well-conducted review and the authors' conclusions appear to reflect the evidence. However, limitations within the included trials should be taken into account when interpreting the conclusion. Authors' objectives To compare intravitreal triamcinolone acetonide injection versus no treatment or sub-Tenon triamcinolone acetonide (STTA

DARE.2009